Helicases are ATP-driven molecular motor proteins that catalyze the unfolding of the duplex polynucleotides. Helicases can provide two separate nucleic acid strands for replication, transcription and recombination in the catalytic process. Helicases are a class of enzymes that unwind hydrogen bonds, which are often dependent on the presence of a single strand and recognize the single-stranded structure of the replication fork. Generally, these enzymes plays an important role in catalyzing the deconvolution of double-stranded DNA or RNA during DNA or RNA replication. Moreover, they are present in all organisms (from viruses and bacteria to mammals), and replication and/or repair of their respective genomes require them. Therefore, DNA helicases are promising drug targets for the treatment of infectious diseases and cancer.
In order to develop the helicase focused library, BOC Sciences is focused on targeting small molecule inhibitors of helicase to find small molecule compounds with desired helicase-related activity for the treatment of a wide range of tumors.
Figure 1. Mechanisms of DNA helicase inhibitors and therapeutic strategies. (Arindam, D.; Robert, M. 2018)
In addition, BOC Sciences provides a high-quality SARS-CoV-2 helicase (NSP13) targeted library to identify small molecules that specifically target the replication apparatus to discover new compounds with activity against SARS-CoV-2
BOC Sciences provides professional, rapid and high-quality services of Helicase Focused Library design at competitive prices for global customers. Personalized and customized services of Helicase Focused Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.